Proteasome Inhibition Results in TRAIL Sensitization of Primary Keratinocytes by Removing the Resistance-Mediating Block of Effector Caspase Maturation

REFERENCES

• Ashkenazi, A., R. C. Pai, S. Fong, S. Leung, D. A. Lawrence, S. A. Marsters, C. Blackie, L. Chang, A. E. McMurtrey, A. Hebert, L. DeForge, I. L. Koumenis, D. Lewis, L. Harris, J. Bussiere, H. Koeppen, Z. Shahrokh, and R. H. Schwall. 1999. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Investig. 104: 155–162.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376: 167–170.
   PubMed Web of Science ®Google Scholar
• Bodmer, J. L., N. Holler, S. Reynard, P. Vinciguerra, P. Schneider, P. Juo, J. Blenis, and J. Tschopp. 2000. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat. Cell Biol. 2: 241–243.
   PubMed Web of Science ®Google Scholar
• Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106: 761–771.
   PubMed Web of Science ®Google Scholar
• Bratton, S. B., G. Walker, S. M. Srinivasula, X. M. Sun, M. Butterworth, E. S. Alnemri, and G. M. Cohen. 2001. Recruitment, activation and retention of caspases-9 and -3 by Apaf-1 apoptosome and associated XIAP complexes. EMBO J. 20: 998–1009.
   PubMed Web of Science ®Google Scholar
• Briegel, K., B. Hentsch, I. Pfeuffer, and E. Serfling. 1991. One base pair change abolishes the T cell-restricted activity of a κB-like proto-enhancer element from the interleukin 2 promoter. Nucleic Acids Res. 19: 5929–5936.
   PubMed Web of Science ®Google Scholar
• Cain, K., D. G. Brown, C. Langlais, and G. M. Cohen. 1999. Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex. J. Biol. Chem. 274: 22686–22692.
   PubMed Web of Science ®Google Scholar
• Chai, J., C. Du, J. W. Wu, S. Kyin, X. Wang, and Y. Shi. 2000. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406: 855–862.
   PubMed Web of Science ®Google Scholar
• Chen, F., D. Chang, M. Goh, S. A. Klibanov, and M. Ljungman. 2000. Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. Cell Growth Differ. 11: 239–246.
   PubMedGoogle Scholar
• Cowling, V., and J. Downward. 2002. Caspase 6 is the direct activator of caspase 8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase 6 prodomain. Cell Death Differ. 9: 1046–1056.
   PubMed Web of Science ®Google Scholar
• Degli-Esposti, M. A., W. C. Dougall, P. J. Smolak, J. Y. Waugh, C. A. Smith, and R. G. Goodwin. 1997. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7: 813–820.
   PubMed Web of Science ®Google Scholar
• Deng, Y., Y. Lin, and X. Wu. 2002. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev. 16: 33–45.
   PubMed Web of Science ®Google Scholar
• Denk, A., M. Goebeler, S. Schmid, I. Berberich, O. Ritz, D. Lindemann, S. Ludwig, and T. Wirth. 2001. Activation of NF-κB via the IκB kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J. Biol. Chem. 276: 28451–28458.
   PubMedGoogle Scholar
• Deveraux, Q. L., and J. C. Reed. 1999. IAP family proteins-suppressors of apoptosis. Genes Dev. 13: 239–252.
   PubMed Web of Science ®Google Scholar
• Deveraux, Q. L., R. Takahashi, G. S. Salvesen, and J. C. Reed. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388: 300–304.
   PubMed Web of Science ®Google Scholar
• Drexler, H. C. 1997. Activation of the cell death program by inhibition of proteasome function. Proc. Natl. Acad. Sci. USA 94: 855–860.
   PubMed Web of Science ®Google Scholar
• Du, C., M. Fang, Y. Li, L. Li, and X. Wang. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33–42.
   PubMed Web of Science ®Google Scholar
• Ekert, P. G., J. Silke, C. J. Hawkins, A. M. Verhagen, and D. L. Vaux. 2001. DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9. J. Cell Biol. 152: 483–490.
   PubMed Web of Science ®Google Scholar
• Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268: 726–731.
   PubMed Web of Science ®Google Scholar
• Gliniak, B., and T. Le. 1999. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. Cancer Res. 59: 6153–6158.
   PubMed Web of Science ®Google Scholar
• Goldstein, J. C., N. J. Waterhouse, P. Juin, G. I. Evan, and D. R. Green. 2000. The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant. Nat. Cell Biol. 2: 156–162.
   PubMed Web of Science ®Google Scholar
• Griffith, T. S., W. A. Chin, G. C. Jackson, D. H. Lynch, and M. Z. Kubin. 1998. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol. 161: 2833–2840.
   PubMed Web of Science ®Google Scholar
• Harper, N., S. N. Farrow, A. Kaptein, G. M. Cohen, and M. MacFarlane. 2001. Modulation of TRAIL-induced NF-κB activation by inhibition of apical caspases. J. Biol. Chem. 276: 34743–34752.
   PubMed Web of Science ®Google Scholar
• Hinz, S., A. Trauzold, L. Boenicke, C. Sandberg, S. Beckmann, E. Bayer, H. Walczak, H. Kalthoff, and H. Ungefroren. 2000. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene 19: 5477–5486.
   PubMed Web of Science ®Google Scholar
• Holcik, M., and R. G. Korneluk. 2001. XIAP, the guardian angel. Nat. Rev. Mol. Cell. Biol. 2: 550–556.
   PubMed Web of Science ®Google Scholar
• Hu, W. H., H. Johnson, and H. B. Shu. 1999. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathways. J. Biol. Chem. 274: 30603–30610.
   PubMed Web of Science ®Google Scholar
• Jeremias, I., C. Kupatt, B. Baumann, I. Herr, T. Wirth, and K. M. Debatin. 1998. Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells. Blood 91: 4624–4631.
   PubMed Web of Science ®Google Scholar
• Jesenberger, V., and S. Jentsch. 2002. Deadly encounter: ubiquitin meets apoptosis. Nat. Rev. Mol. Cell. Biol. 3: 112–121.
   PubMed Web of Science ®Google Scholar
• Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Ann. Rev. Immunol. 18: 621–663.
   PubMed Web of Science ®Google Scholar
• Karin, M., and A. Lin. 2002. NF-κB at the crossroads of life and death. Nat. Immunol. 3: 221–227.
   PubMed Web of Science ®Google Scholar
• Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10: 640–648.
   PubMed Web of Science ®Google Scholar
• Keogh, S. A., H. Walczak, L. Bouchier-Hayes, and S. J. Martin. 2000. Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis. FEBS Lett. 471: 93–98.
   PubMed Web of Science ®Google Scholar
• Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and M. E. Peter. 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579–5588.
   PubMed Web of Science ®Google Scholar
• Kischkel, F. C., D. A. Lawrence, A. Chuntharapai, P. Schow, K. J. Kim, and A. Ashkenazi. 2000. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12: 611–620.
   PubMed Web of Science ®Google Scholar
• Kischkel, F. C., D. A. Lawrence, A. Tinel, H. LeBlanc, A. Virmani, P. Schow, A. Gazdar, J. Blenis, D. Arnott, and A. Ashkenazi. 2001. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J. Biol. Chem. 276: 46639–46646.
   PubMed Web of Science ®Google Scholar
• Koepp, D. M., J. W. Harper, and S. J. Elledge. 1999. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell 97: 431–434.
   PubMed Web of Science ®Google Scholar
• Kroemer, G., and J. C. Reed. 2000. Mitochondrial control of cell death. Nat. Med. 6: 513–951.
   PubMed Web of Science ®Google Scholar
• Krueger, A., I. Schmitz, S. Baumann, P. H. Krammer, and S. Kirchhoff. 2001. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276: 20633–20640.
   PubMed Web of Science ®Google Scholar
• Laney, J. D., and M. Hochstrasser. 1999. Substrate targeting in the ubiquitin system. Cell 97: 427–430.
   PubMed Web of Science ®Google Scholar
• Lazebnik, Y. A., S. H. Kaufmann, S. Desnoyers, G. G. Poirier, and W. C. Earnshaw. 1994. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346–347.
   PubMed Web of Science ®Google Scholar
• LeBlanc, H., D. A. Lawrence, E. Varfolomeev, K. Totpal, J. Morlan, P. Schow, S. Fong, R. Schwall, D. Sinicropi, and A. Ashkenazi. 2002. Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat. Med. 8: 274–281.
   PubMed Web of Science ®Google Scholar
• Leverkus, M., M. Neumann, T. Mengling, C. T. Rauch, E. B. Brücker, P. H. Krammer, and H. Walczak. 2000. Regulation of TRAIL sensitivity in primary and transformed human keratinocytes. Cancer Res. 60: 553–559.
   PubMed Web of Science ®Google Scholar
• Leverkus, M., H. Walczak, H.-W. Fries, G. Terbeck, A. McLellan, E.-B. Brücker, and E. Kämpgen. 2000. Maturation of dendritic cells leads to upregulation of cellular FLICE-inhibitory protein (cFLIP) and concomitant downregulation of death receptor mediated apoptosis. Blood 110: 353–357.
   Google Scholar
• Leverkus, M., M. Yaar, and B. A. Gilchrest. 1997. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp. Cell Res. 232: 255–262.
   PubMed Web of Science ®Google Scholar
• Liu, Z., C. Sun, E. T. Olejniczak, R. P. Meadows, S. F. Betz, T. Oost, J. Herrmann, J. C. Wu, and S. W. Fesik. 2000. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature 408: 1004–1008.
   PubMed Web of Science ®Google Scholar
• Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The tumor necrosis factor and tumor necrosis factor receptor superfamilies: integrating mammalian biology. Cell 104: 487–501.
   PubMed Web of Science ®Google Scholar
• MacFarlane, M., W. Merrison, S. B. Bratton, and G. M. Cohen. 2002. Proteasome-mediated degradation of Smac during apoptosis:XIAP promotes Smac ubiquitination in vitro. J. Biol. Chem. 277: 36611–36616.
   PubMed Web of Science ®Google Scholar
• Marienfeld, R., F. Berberich-Siebelt, I. Berberich, A. Denk, E. Serfling, and M. Neumann. 2001. Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-κB control. Oncogene 20: 8142–8147.
   PubMedGoogle Scholar
• Martins, L. M. 2002. The serine protease Omi/HtrA2: a second mammalian protein with a Reaper-like function. Cell Death Differ. 9: 699–701.
   PubMed Web of Science ®Google Scholar
• Masdehors, P., H. Merle-Beral, H. Magdelenat, and J. Delic. 2000. Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation. Leukemia Lymphoma 38: 499–504.
   PubMed Web of Science ®Google Scholar
• Medema, J. P., C. Scaffidi, P. H. Krammer, and M. E. Peter. 1998. Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J. Biol. Chem. 273: 3388–3393.
   PubMedGoogle Scholar
• Meng, L., R. Mohan, B. H. Kwok, M. Elofsson, N. Sin, and C. M. Crews. 1999. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc. Natl. Acad. Sci. USA 96: 10403–10408.
   PubMed Web of Science ®Google Scholar
• Neumann, M., T. Grieshammer, S. Chuvpilo, B. Kneitz, M. Lohoff, A. Schimpl, B. R. Franza, Jr., and E. Serfling. 1995. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14: 1991–2004.
   PubMed Web of Science ®Google Scholar
• Nicholson, D. W. 1999. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6: 1028–1042.
   PubMed Web of Science ®Google Scholar
• Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773–785.
   PubMed Web of Science ®Google Scholar
• Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271: 12687–12690.
   PubMed Web of Science ®Google Scholar
• Roy, S., C. I. Bayly, Y. Gareau, V. M. Houtzager, S. Kargman, S. L. C. Keen, K. Rowland, I. M. Seiden, N. A. Thornberry, and D. W. Nicholson. 2001. Maintenance of caspase-3 proenzyme dormancy by an intrinsic “safety catch” regulatory tripeptide. Proc. Natl. Acad. Sci. USA 98: 6132–6137.
   PubMed Web of Science ®Google Scholar
• Roy, S., and D. W. Nicholson. 2000. Cross-talk in cell death signalling. J. Exp. Med. 192: F21–F25.
   PubMed Web of Science ®Google Scholar
• Scaduto, R. C., Jr., and L. W. Grotyohann. 1999. Measurement of mitochondrial membrane potential with fluorescent rhodamine derivatives. Biophys. J. 76: 469–477.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675–1687.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., I. Schmitz, P. H. Krammer, and M. E. Peter. 1999. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274: 1541–1548.
   PubMed Web of Science ®Google Scholar
• Schneider, P., M. Thome, K. Burns, J. L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, and J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7: 831–836.
   PubMed Web of Science ®Google Scholar
• Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with ′mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17: 6419–6424.
   PubMed Web of Science ®Google Scholar
• Shi, Y. 2002. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9: 459–470.
   PubMed Web of Science ®Google Scholar
• Silke, J., P. G. Ekert, C. L. Day, C. J. Hawkins, M. Baca, J. Chew, M. Pakusch, A. M. Verhagen, and D. L. Vaux. 2001. Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP. EMBO J. 20: 3114–3123.
   PubMedGoogle Scholar
• Single, B., M. Leist, and P. Nicotera. 1998. Simultaneous release of adenylate kinase and cytochrome c in cell death. Cell Death Differ. 5: 1001–1003.
   PubMed Web of Science ®Google Scholar
• Sprick, M. R., E. Rieser, H. Stahl, A. Grosse-Wilde, M. A. Weigand, and H. Walczak. 2002. Caspase 10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner. EMBO J. 21: 4520–4530.
   PubMed Web of Science ®Google Scholar
• Sprick, M. R., M. A. Weigand, E. Rieser, C. T. Rauch, P. Juo, J. Blenis, P. H. Krammer, and H. Walczak. 2000. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12: 599–609.
   PubMed Web of Science ®Google Scholar
• Sun, X. M., S. B. Bratton, M. Butterworth, M. MacFarlane, and G. M. Cohen. 2002. Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J. Biol. Chem. 277: 11345–11351.
   PubMedGoogle Scholar
• Suzuki, Y., Y. Nakabayashi, and R. Takahashi. 2001. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3. Proc. Natl. Acad. Sci. USA 98: 8662–8667.
   PubMed Web of Science ®Google Scholar
• Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456–1562.
   PubMed Web of Science ®Google Scholar
• Thornberry, N. A., E. P. Peterson, J. J. Zhao, A. D. Howard, P. R. Griffin, and K. T. Chapman. 1994. Inactivation of interleukin-1 beta converting enzyme by peptide (acyloxy)methyl ketones. Biochemistry 33: 3934–3940.
   PubMed Web of Science ®Google Scholar
• van Loo, G., X. Saelens, M. van Gurp, M. MacFarlane, S. J. Martin, and P. Vandenabeele. 2002. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 9: 1031–1042.
   PubMed Web of Science ®Google Scholar
• Verhagen, A. M., P. G. Ekert, M. Pakusch, J. Silke, L. M. Connolly, G. E. Reid, R. L. Moritz, R. J. Simpson, and D. L. Vaux. 2000. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43–53.
   PubMed Web of Science ®Google Scholar
• Wagenknecht, B., M. Hermisson, P. Groscurth, P. Liston, P. H. Krammer, and M. Weller. 2000. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J. Neurochem. 75: 2288–2297.
   PubMed Web of Science ®Google Scholar
• Wajant, H., E. Haas, R. Schwenzer, F. Muhlenbeck, S. Kreuz, G. Schubert, M. Grell, C. Smith, and P. Scheurich. 2000. Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD). J. Biol. Chem. 275: 24357–24366.
   PubMedGoogle Scholar
• Walczak, H., A. Bouchon, H. Stahl, and P. H. Krammer. 2000. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Cancer Res. 60: 3051–3057.
   PubMed Web of Science ®Google Scholar
• Walczak, H., M. A. Degli-Esposti, R. S. Johnson, P. J. Smolak, J. Y. Waugh, N. Boiani, M. S. Timour, M. J. Gerhart, K. A. Schooley, C. A. Smith, R. G. Goodwin, and C. T. Rauch. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16: 5386–5397.
   PubMed Web of Science ®Google Scholar
• Walczak, H., and P. H. Krammer. 2000. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp. Cell Res. 256: 58–66.
   PubMed Web of Science ®Google Scholar
• Walczak, H., R. E. Miller, K. Ariail, B. Gliniak, T. S. Griffith, M. Kubin, W. Chin, J. Jones, A. Woodward, T. Le, C. Smith, P. Smolak, R. G. Goodwin, C. T. Rauch, J. C. Schuh, and D. H. Lynch. 1999. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5: 157–163.
   PubMed Web of Science ®Google Scholar
• Walczak, H., and M. R. Sprick. 2001. Biochemistry and function of the DISC. Trends Biochem. Sci. 26: 452–453.
   PubMedGoogle Scholar
• Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17: 331–367.
   PubMed Web of Science ®Google Scholar
• Wang, C. Y., M. W. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin, Jr. 1998. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680–1683.
   PubMed Web of Science ®Google Scholar
• Wang, J., H. J. Chun, W. Wong, D. M. Spencer, and M. J. Lenardo. 2001. Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. USA 98: 13884–13888.
   PubMed Web of Science ®Google Scholar
• Wehrli, P., I. Viard, R. Bullani, J. Tschopp, and L. E. French. 2000. Death receptors in cutaneous biology and disease. J. Investig. Dermatol. 115: 141–148.
   PubMed Web of Science ®Google Scholar
• Wiley, S. R., K. Schooley, P. J. Smolak, W. S. Din, C. P. Huang, J. K. Nicholl, G. R. Sutherland, T. D. Smith, C. Rauch, C. A. Smith, and R. G. Goodwin. 1995. Identification and characterization of a new member of the tumor necrosis factor family that induces apoptosis. Immunity 3: 673–682.
   PubMed Web of Science ®Google Scholar
• Wu, M. X., Z. Ao, K. V. Prasad, R. Wu, and S. F. Schlossman. 1998. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 281: 998–1001.
   PubMed Web of Science ®Google Scholar
• Zhao, J., T. Tenev, L. M. Martins, J. Downward, and N. R. Lemoine. 2000. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J. Cell Sci. 113: 4363–4371.
   PubMed Web of Science ®Google Scholar